Literature DB >> 31463894

Serum lipase as a biomarker for early prediction and diagnosis of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Yu Zhang1,2, Xiaoling Ye1,2, Xinyue Wan1,2, Tao Deng3,4.   

Abstract

BACKGROUND: Lipase is one of the diagnostic criteria for acute pancreatitis; however, the value of serum lipase in the early prediction and diagnosis for post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis remains controversial. AIMS: We evaluate the 3-h post-ERCP serum amylase and lipase activities for early prediction of postoperative pancreatitis (PEP) and compare the 24-h post-ERCP serum amylase and lipase activities in the diagnosis of PEP.
METHODS: Clinical information of patients who underwent ERCP from January 2017 to December 2018 at our hospital were retrospectively reviewed. Receiver operating characteristic (ROC) curves were performed for 3-h and 24-h post-ERCP serum amylase and lipase activities to evaluate predictive and diagnostic values, respectively.
RESULTS: A total of 498 cases with ERCP were finally enrolled, in which 36 cases of PEP were confirmed. ROC curves for 3-h post-ERCP amylase and lipase activities depicted areas under the curve (AUCs) of 0.88 (P < 0.001, 95% confidence intervals [CI] 0.82-0.93) and 0.90 (P < 0.001, 95% CI 0.86-0.93), respectively. The difference showed no significance using Z test (Z = 0.69, P > 0.05). AUCs for 24-h amylase and lipase activities were 0.83 (P < 0.001, 95% CI 0.77-0.89) and 0.94 (P < 0.001, 95% CI 0.90-0.99), respectively, and the difference was significant (Z = 3.04, P < 0.05).
CONCLUSIONS: For early prediction of PEP, 3-h post-ERCP serum lipase activity is at least as good as that of amylase. For diagnosis of PEP, 24-h post-ERCP serum lipase is a much better indicator than that of amylase. Together, this study suggests that serum lipase should be given priority in the early prediction and diagnosis of PEP.

Entities:  

Keywords:  Amylase; Diagnosing; Lipase; Pancreatitis; Post-ERCP; ROC

Mesh:

Substances:

Year:  2019        PMID: 31463894     DOI: 10.1007/s11845-019-02089-2

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  36 in total

Review 1.  Rectal NSAIDs for the prevention of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.

Authors:  Hong-Li Sun; Bing Han; Hong-Peng Zhai; Xin-Hua Cheng; Kai Ma
Journal:  Surgeon       Date:  2013-12-09       Impact factor: 2.392

2.  Using the 4-hour Post-ERCP amylase level to predict post-ERCP pancreatitis.

Authors:  Verity R Sutton; Michael K Y Hong; Peter R Thomas
Journal:  JOP       Date:  2011-07-08

3.  A Randomized Trial of Topical Epinephrine and Rectal Indomethacin for Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients.

Authors:  Ayesha Kamal; Venkata S Akshintala; Rupjyoti Talukdar; Mahesh K Goenka; Rakesh Kochhar; Sundeep Lakhtakia; Mohan K Ramchandani; Saroj Sinha; Rajesh Goud; Vijay K Rai; Manu Tandan; Rajesh Gupta; B Joseph Elmunzer; Saowonee Ngamruengphong; Vivek Kumbhari; Mouen A Khashab; Anthony N Kalloo; D Nageshwar Reddy; Vikesh K Singh
Journal:  Am J Gastroenterol       Date:  2019-02       Impact factor: 10.864

4.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

Review 5.  Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials.

Authors:  Árpád Patai; Norbert Solymosi; László Mohácsi; Árpád V Patai
Journal:  Gastrointest Endosc       Date:  2017-02-04       Impact factor: 9.427

6.  Pancreatitis with normal lipase and amylase in setting of end-stage renal disease.

Authors:  Anuj Sharma; Umair Masood; Babar Khan; Kunal Chawla; Divey Manocha
Journal:  Am J Emerg Med       Date:  2017-07-05       Impact factor: 2.469

7.  Predicting post-endoscopic retrograde cholangiopancreatography pancreatitis using the 4-h serum lipase level.

Authors:  Alexander Papachristos; Tess Howard; Benjamin N Thomson; Peter R Thomas
Journal:  ANZ J Surg       Date:  2016-07-25       Impact factor: 1.872

Review 8.  Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.

Authors:  Ali Akbar; Barham K Abu Dayyeh; Todd H Baron; Zhen Wang; Osama Altayar; Mohammad Hassan Murad
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-30       Impact factor: 11.382

9.  Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus.

Authors:  Peter A Banks; Thomas L Bollen; Christos Dervenis; Hein G Gooszen; Colin D Johnson; Michael G Sarr; Gregory G Tsiotos; Santhi Swaroop Vege
Journal:  Gut       Date:  2012-10-25       Impact factor: 23.059

10.  Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure.

Authors:  Kei Ito; Naotaka Fujita; Yutaka Noda; Go Kobayashi; Jun Horaguchi; Osamu Takasawa; Takashi Obana
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

View more
  1 in total

1.  Early prediction of post-ERCP pancreatitis by post-procedure amylase and lipase levels: A systematic review and meta-analysis.

Authors:  Hemant Goyal; Sonali Sachdeva; Syed Ali Amir Sherazi; Shweta Gupta; Abhilash Perisetti; Aman Ali; Saurabh Chandan; Benjamin Tharian; Neil Sharma; Nirav Thosani
Journal:  Endosc Int Open       Date:  2022-07-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.